Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

NCT00777816 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: XOMA 052
DRUG: Placebo

Sponsor

XOMA (US) LLC